ArticleActa neurologica Belgica2025
Efficacy of ocrelizumab versus rituximab in patients with relapsing-remitting multiple sclerosis.
Nesma Mounir et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this paperpooled itcites it